Overview
Cognito Therapeutics develops non-invasive neuromodulation devices designed to modulate brain activity and support brain health through white matter preservation and brain plasticity enhancement. The company focuses on medical device solutions for neurodegenerative diseases, including Alzheimer's disease, with a mission to support brain function and cognitive health.
More in Neurotechnology
Latest industry news
Vagus Nerve Stimulation Enters the Sports Performance Arena With New Anxiety Support Device
2026-09-22 · Product
Aurenar Raises $5.7M to Accelerate Stroke Neuromodulation Device Development
2026-09-21 · Funding
UCANACT Raises €800,000 to Advance Brain-Computer Communication Technology
2026-09-20 · Funding
Tether Evo Takes On One of BCI's Hardest Engineering Problems
2026-09-19 · Research
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →